Uncategorised - European Medical Journal

Bispecific Antibodies for Haematologic Malignancies

This infographic explores the current impact and future potential of bispecific antibodies in haematological malignancies…

Our Latest Allergy & Immunology Journal

The latest edition of EMJ Allergy & Immunology is now live, distilling high-impact insights and the biggest advances from EAACI 2026 into…

Review of the European Hematology Association (EHA) 2026 Congress

THE EUROPEAN Hematology Association (EHA) 2026 Congress was a strong testament to the rapidly evolving field of haematology. From the…

Editor's Pick: Anti-BCMA CAR-T Therapy in Dialysis-Dependent RRMM Patients

Renal impairment remains a defining and prognostically adverse complication of multiple myeloma, and up to half the patients have renal…

Review of the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026

THE HISTORIC city of Istanbul, Türkiye, provided the backdrop for the 70th Annual Congress of the European Academy of Allergy and Clinical…

Editor's Pick: Biologics in High-Risk Asthma

Asthma is a chronic respiratory disease affecting more than 300 million people worldwide, characterised by variable symptoms and airflow…

Clustering Tree Allergens Reveals Immunotherapy-Relevant Profiles

Polysensitisation to tree pollen allergens is a central challenge in the diagnosis and management of respiratory allergy, particularly in…

Endovascular Profiles in ACE Inhibitor-Induced Angioedema in a South African Cohort

Angiotensin-converting enzyme inhibitor-induced angioedema (AE-ACEI) is more frequent in Black African populations.1,2 Although bradykinin…

Omics and Allergic Diseases: Fact or Fiction

OMICS technologies are focused on the massive analysis of systems biology levels. This means analysis of the different steps in the…

Evolving Concepts and Therapies in Sickle Cell Anaemia and HbSC Disease

It was an exciting time for championing progress in sickle cell disease (SCD) at the European Hematology Association (EHA) Congress 2026…